Cambridge, Massachusetts, United StatesFounded 201324+ employeesPrivate
$59.7M raisedSeries A· last: series a (Apr 2024)· 24 rounds
Backed by(46 investors)
HelixNano is building the world's most advanced mRNA platform to enable previously impossible applications across human and non-human biology
